• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

cell therapy

Biotechnology for Menopause and Infertility
Posted inIn the Pipeline, Pharma & Biotech

Biotechnology for Menopause and Infertility

June 23, 2022September 8, 2022

Is it possible to prolong a women’s health and ability to get pregnant?

Redasemtide: Universal Medicine for Regeneration of Any Tissue
Posted inClinical Trials, Metabolism, Neuroscience, Rare/Orphan Diseases

Redasemtide: Universal Medicine for Regeneration of Any Tissue

February 12, 2022September 8, 2022

Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.

Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma

January 27, 2022September 8, 2022

Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.

nurse
Posted inClinical Trials, COVID-19, Infections

MesenCure: Israeli Miracle Drug Saves From Death by COVID-19

January 25, 2022September 8, 2022

A cell therapy developed by Bonus BioGroup is amazingly able to fight coronavirus and its most severe complications.

T cell.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Even Severe Multiple Sclerosis Can Be Cured

January 11, 2022September 8, 2022

Atara Biotherapeutics and its awesome T-cell therapy against Epstein–Barr virus can really cure progressive forms of multiple sclerosis.

GammaDelta Therapeutics.
Posted inMergers & Acquisitions, Oncology

Takeda Bets on Promising Gamma Delta T-cell Immunotherapy

October 28, 2021September 8, 2022

UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News